VTE Risk After Joint Replacement: Does Anticoagulant Choice Matter?
(MedPage Today) -- Among younger patients undergoing total hip or knee replacement, whether they received aspirin versus direct oral anticoagulants (DOACs) did not seem to affect their risk of venous thromboembolism (VTE) following surgery, a large... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 1, 2023 Category: Cardiology Source Type: news

Low-Dose Aspirin: No Flares in Pregnant Patients With IBD Low-Dose Aspirin: No Flares in Pregnant Patients With IBD
Low-dose aspirin is recommended for pregnant women who are at risk of hypertensive disorders, such as eclampsia, preeclampsia, and gestational diabetes.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 29, 2023 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Doctors issue warning to aspirin users about serious side effects
Bleeding more than usual, including if you spot blood in your poo, could be a side effect of taking the tablet. (Source: Daily Express - Health)
Source: Daily Express - Health - November 25, 2023 Category: Consumer Health News Source Type: news

Low-Dose Aspirin Reduces Liver Fat, Inflammation Markers Low-Dose Aspirin Reduces Liver Fat, Inflammation Markers
A single daily low dose of aspirin significantly reduced hepatic fat fraction and liver transaminase levels in a randomized trial in patients with metabolic-associated steatotic liver disease.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 16, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

AHA: Avoidance of Aspirin Noninferior With LVAD in Advanced Heart Failure
THURSDAY, Nov. 16, 2023 -- Avoidance of aspirin as part of an antithrombotic regimen that includes a vitamin K agonist (VKA) is noninferior to an aspirin-containing regimen for patients with advanced heart failure receiving support from a fully... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2023 Category: Pharmaceuticals Source Type: news

ARTESIA Doesn't Answer a Common Question in Cardiology ARTESIA Doesn't Answer a Common Question in Cardiology
The trial on apixaban vs aspirin in subclinical atrial fibrillation did not provide an easy answer on whether to anticoagulate patients with these common arrhythmias, writes John Mandrola, MD.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 15, 2023 Category: Cardiology Tags: Cardiology Commentary Source Type: news

AHA: Apixaban Beneficial for Patients With Subclinical A-Fib
TUESDAY, Nov. 14, 2023 -- Apixaban results in a lower risk for stroke or systemic embolism than aspirin for patients with subclinical atrial fibrillation, according to a study published online Nov. 12 in the New England Journal of Medicine to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 14, 2023 Category: Pharmaceuticals Source Type: news

Late-Breaking Data Show an Aspirin-Free Medication Regimen Benefits People with Abbott's HeartMate 3 ™ Heart Pump
(Source: Abbott.com)
Source: Abbott.com - November 13, 2023 Category: Pharmaceuticals Source Type: news

Dropping Aspirin Cuts Bleeding in LVAD Patients Dropping Aspirin Cuts Bleeding in LVAD Patients
A randomized trial evaluating vitamin K therapy with aspirin or placebo with a left ventricular assist device shows avoiding aspirin reduced bleeding without increasing thrombotic risk.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - November 13, 2023 Category: Transplant Surgery Tags: Cardiology News Source Type: news

Dropping Aspirin Cuts Bleeding in LVAD Patients Dropping Aspirin Cuts Bleeding in LVAD Patients
A randomized trial evaluating vitamin K therapy with aspirin or placebo with a left ventricular assist device shows avoiding aspirin reduced bleeding without increasing thrombotic risk.MDedge News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - November 13, 2023 Category: Internal Medicine Tags: Cardiology News Source Type: news

No Aspirin Needed After LVAD, ARIES-HM3 Trial Says
(MedPage Today) -- PHILADELPHIA -- Dropping aspirin from the antithrombotic regimen after HeartMate 3 left ventricular assist device (LVAD) implantation appeared safer than the usual combination approach in the ARIES-HM3 trial. Atop warfarin... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 12, 2023 Category: Cardiology Source Type: news

Weight Loss Drug Wegovy Can Also Reduce Risk of Serious Heart Events, Study Shows
Popular weight loss drugs have dominated news headlines and social media, mostly for their ability to help people shed pounds and control diabetes. But now there is evidence that one of the drugs, semaglutide, can also help reduce the risk of dying from heart disease in some patients. The drug semaglutide is sold under the brand names Wegovy, Ozempic, and Rybelsus. This trial, however, only studied the effects of Wegovy, which is semaglutide at 2.4mg in injectable form, and currently approved for weight management. The results of a much-anticipated study, sponsored by semaglutide’s maker Novo Nordisk, investigating t...
Source: TIME: Health - November 11, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news

Why is pre-eclampsia still causing the deaths of mothers and their babies?
The condition affects up to 6% of all pregnancies yet understanding of its causes and how to treat it remains basicHaving had one normal pregnancy, Emma Bailey assumed that her second experience of childbirth would progress relatively smoothly. But, at 34 weeks, she began to suffer sudden bursts of stabbing pain just underneath her ribcage.“It was really excruciating pain,” she remembers. “I was admitted to hospital, but they sent me home, saying it was probably just anxiety. I then had to be readmitted the very next day because I was in agony.”Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - November 11, 2023 Category: Science Authors: David Cox Tags: Science Pregnancy Health Maternal mortality Stroke Heart attack High blood pressure Infant and child mortality UK news Aspirin Parents and parenting Medical research Bill and Melinda Gates Foundation Source Type: news

No Harm in Short Aspirin Duration After PCI for ACS No Harm in Short Aspirin Duration After PCI for ACS
Less than a month of ticagrelor plus aspirin therapy followed by ticagrelor alone for 1 year after PCI for ACS was noninferior to dual antiplatelet therapy in the T-PASS trial.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 8, 2023 Category: Intensive Care Tags: Cardiology News Source Type: news

ACG: Prophylactic Low-Dose Aspirin in Pregnancy Does Not Increase IBD Activity
THURSDAY, Oct. 26, 2023 -- Use of low-dose aspirin (LDA) among pregnant women with inflammatory bowel disease (IBD) is not associated with an increased risk for disease activity, according to a study presented at the annual meeting of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 26, 2023 Category: Pharmaceuticals Source Type: news